CD73 exhibits aberrant N-linked glycosylation in HCC cells and is independent of HCC etiology, tumor stage, or fibrosis presence. Aberrant glycosylation of CD73 results in a 3-fold decrease in enzyme activity;CD73 does not correlate with tumor immune subtype in HCC. Here, NT5E is linked to neoplasm.